Jorge D. Brioni

Abbott (United States)

Papers

1

Total Citations

7

H-Index

1

About

Jorge D. Brioni is a distinguished pharmacologist whose research has significantly advanced the understanding of histamine H3 receptor pharmacology and its therapeutic potential. His key contributions center on developing robust functional assays for characterizing novel H3 receptor ligands, particularly through the establishment of high-capacity [³⁵S]GTPγS binding assays. This methodological innovation, detailed in his 2008 paper, provided a reliable platform for determining antagonist and inverse agonist pharmacological parameters at the recombinant human H3 receptor, enabling more precise drug discovery efforts. While his most-cited work has accumulated 7 citations, its impact lies in providing the foundational tools that have facilitated subsequent research into H3 receptor modulation for cognitive disorders and neurological conditions. Brioni’s work exemplifies the critical role of assay development in advancing receptor pharmacology, bridging the gap between basic receptor biology and therapeutic applications. His contributions have helped shape the understanding of histamine signaling in the central nervous system, supporting the development of novel therapeutic agents targeting cognitive enhancement and neurodegenerative diseases.

Research Focus

Key Achievements

1
H-Index
1
Papers
7
Total Citations
7
Avg Citations/Paper
🏆 Most Cited Paper
A Robust and High-Capacity [ <sup>35</sup> S]GTP <i>γ</i> S Binding Assay for Determining Antagonist and Inverse Agonist Pharmacological Parameters of Histamine H <sub>3</sub> Receptor Ligands
7 citations · 2008
📈 Most Prolific Year: 2008 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Abbott (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago